Showing 8511-8520 of 20416 results for "".
Reducing Complications of High Blood Pressure in Older Adults
https://reachmd.com/programs/the-jama-report/reducing-complications-high-blood-pressure-older-adults/8194/A recent study examined the best target blood pressure to reduce the risks of heart attack, heart failure and stroke in older adults.Cholesterol Management in Children
https://reachmd.com/programs/lipid-luminations/cholesterol-management-in-children/3624/Host Dr. Larry Kaskel welcomes Dr. Don Wilson, professor and chair of pediatrics at the Texas A&M Health Sciences Center College of Medicine, to offer his counsel on the latest guidelines for pediatric cholesterol management. Why was this the time to revise previous recommendations? How do riskReforming the FDA's Drug Approval Process
https://reachmd.com/programs/heart-matters/reforming-the-fdas-drug-approval-process/4285/It takes a substantial measure of time, money and manpower to bring a new drug from the bench to the marketplace. One key aspect of this sequence is the drug approval process, overseen by the Food and Drug Administration (FDA). Host Dr. Jack Lewin welcomes Dr. Mark McClellan, director of the EngelbeThe LEVEL UP Trial: Comparing Atopic Dermatitis Treatments
https://reachmd.com/programs/clinicians-roundtable/the-level-up-trial-comparing-atopic-dermatitis-treatments/27070/Explore a recent trial examining the efficacy of upadacitinib and dupilumab in atopic dermatitis patients.Ditch the PowerPoint Slides: You Are the Message
https://reachmd.com/programs/speaking-of/ditch-powerpoint-slides-you-are-message/10111/YOU are the message, not your slides. Learn how to properly use slides when giving a presentation.Pediatric Metabolic Syndrome
https://reachmd.com/programs/lipid-luminations/pediatric-metabolic-syndrome/4545/A series of well-established risk factors define the metabolic syndrome in adults. The situation is less clear for our younger patients, as they typically do not develop cardiovascular disease or experience cardiac events. The key for kids, it seems, is to determine their risk for disease in adulthoNeural Network Models of Depression
https://reachmd.com/programs/clinicians-roundtable/neural-network-models-of-depression/3837/Dr. Helen Mayberg, professor of psychiatry and neurology at Emory University School of Medicine, joins host Dr. Cathleen Margolin to discuss neural network models of depression. Sharing more than two decades of work in this area, Dr. Mayberg explains how models of mood regulation have led to the devIs there a critical window to begin Hormone Replacement Therapy? Does it really exist?
https://reachmd.com/programs/advances-in-womens-health/is-there-a-critical-window-to-begin-hormone-replacement-therapy-does-it-really-exist/3162/During the 1990's multiple studies suggested hormone replacement therapy would decrease heart disease in women and prolong life. Many doctors encouraged their patients to take estrogen even if they didn't have menopausal symptoms. Dr. Veronica Ravnikar discusses optimizing cardiovascular and cognideCode MI: Another Tool to Assess Patient's MI Risk
https://reachmd.com/programs/clinicians-roundtable/decode-mi-another-tool-to-assess-patients-mi-risk/3291/Are we already able to assess our patients accurately for MI risk factors or is there another test that could provide more accuracy? Our guest today, Dr. Jeffrey Gulcher, chief scientific officer and co-founder of deCode Genetics tells host, Dr. Larry Kaskel about deCode MI. Learn how toUnderstanding Vutrisiran’s Cardiac Effects in HELIOS-B
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/understanding-vutrisirans-cardiac-effects-in-helios-b/49038/The HELIOS-B trial found that vutrisiran therapy caused significant reductions in mortality and cardiovascular events in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). In this episode, Dr. Karola Jering joins Dr. Steve Jackson to discuss a secondary analysis of HELIOS-B, which further